Concepedia

Sivakumar Vijayaraghavalu

SV

Statistics

Publications

16

Citations

638

H-Index

13

Active since

2007

Affiliations

Cleveland Clinic Lerner College of Medicine(Current)

Cleveland Clinic

Manipur University

University of North Texas

University of North Texas Health Science Center

Sivakumar Vijayaraghavalu is an author at Cleveland Clinic Lerner College of Medicine specializing in drug delivery, pharmacology, and nanomedicine.

ORCID

Publications per year

2007–2025

16

Publications

16

Drug Resistance in Breast Cancer Cells: Biophysical Characterization of and Doxorubicin Interactions with Membrane Lipids

Chiranjeevi Peetla, Radhika Bhave, Sivakumar Vijayaraghavalu et al. · Molecular Pharmaceutics · 2010 · 159 citations

, , +17

Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of<i>p21</i>Gene Expression Leading to G2/M Cycle Arrest

Sivakumar Vijayaraghavalu, Josephine K. Dermawan, Venugopalan Cheriyath et al. · Molecular Pharmaceutics · 2012 · 84 citations

, , +17

Epigenetic Modulation of the Biophysical Properties of Drug-Resistant Cell Lipids to Restore Drug Transport and Endocytic Functions

Sivakumar Vijayaraghavalu, Chiranjeevi Peetla, Shan Lu et al. · Molecular Pharmaceutics · 2012 · 79 citations

, , +17

Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion

Sivakumar Vijayaraghavalu, Vinod Labhasetwar · Cancer Letters · 2013 · 46 citations · Full text

, , +16

Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis

Sivakumar Vijayaraghavalu, Yue Gao, Mohammed Tanjimur Rahman et al. · Biomaterials · 2019 · 42 citations · Full text

, , +17

1–5 of 16